This course is for nurse practitioners and advanced practice providers who want to use GLP-1 receptor agonists at sub-therapeutic doses as a precision metabolic and longevity tool either in an existing cash-based wellness practice or as a new service line
People lose an average 8% of their starting weight in 56 weeks on the maintenance dose
5.4 Comparison with other anti-obesity medications The latest generation of GLP-1 receptor agonists signifies a substantial therapeutic improvement compared to earlier alternatives
With GLP-1-reduced appetite, supplementation is almost always necessary for at least sodium, magnesium, and often calcium
Alternatives to compounded semaglutide If you want to buy brand-name semaglutide, you can consider buying Ozempic, Rybelsus, and Wegovy
However, there may be a rare case where you may